22 Sep 16 14 Feb 20

Global Health Review - 14 February 2020

This week, in Vaccine, MSF evaluates the stability of measles vaccine outside the cold chain under extended controlled temperature conditions, revealing that the vaccine’s potency remains above the minimum threshold for 6 days at 37 °C and 2 days at 40 °C. This could be an advantage for outbreak response in isolated and difficult to reach areas. In PLOS ONE, MSF assesses self-reported quality of life among people co-infected with HIV and visceral leishmaniasis in Bihar, India, finding inadequate social support and referral pathways that did not meet patient needs and negatively impacted patients’ quality of life.

In WHO Bulletin, MSF contributes to an article examining the improvements in geospatial health data and the subsequent increase in microtargeting of the HIV response, based on location, risk, clinical status, and disease burden. The authors argue that this microtargeting – despite showing promise for achieving control of the epidemic – could distort health systems, impede integration, and threaten broader health goals. In International Journal of Infectious Diseases, MSF contributes to updated clinical guidance on multi-drug resistant tuberculosis (MDR-TB) by the Global Tuberculosis Network.

In Conflict and Health, MSF operations are mentioned in a qualitative study examining the trauma response during the Battle of Mosul, Iraq, and a BMJ opinion piece shares experiences from an MSF mental health clinic for migrants and refugees in Greece and reacts to plans announced by the Greek government to build a floating sea barrier to deter migrants.  Finally, The Lancet announces a new global commission on migration to increase and support multidisciplinary research focused on migrant and refugee health.

sign up to receive as an email

Neglected tropical diseases

PLoS ONE • Article: ***MSF AUTHOR***: Quality of life perceptions amongst patients co-infected with Visceral Leishmaniasis and HIV: A qualitative study from Bihar, India 

PLoS NTDs • Article: The Galabat-Metema cross-border onchocerciasis focus: The first coordinated interruption of onchocerciasis transmission in Africa

PLoS NTDs • Article: “Buruli ulcer and leprosy, they are intertwined”: Patient experiences of integrated case management of skin neglected tropical diseases in Liberia

Climate change and planetary health

PLoS Medicine • Perspective: Improving air quality needs to be a policy priority for governments globally


Vaccine • Article ***MSF AUTHOR***: Evaluation of the stability of measles vaccine out of the cold chain under extended controlled temperature conditions 

PLoS NTDs • Article: Impact of flavivirus vaccine-induced immunity on primary Zika virus antibody response in humans

The Lancet Infectious Diseases • Article: PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled study and comment: Towards protective immune responses against malaria in pregnant women

BMJ Opinion • Blog: Why do we wait until emergency vaccines are necessary before recognising we need them?

BMJ • News: Targeted measles and rubella vaccination campaign aims to stop global surge in cases

WHO Bulletin • Article: Addressing the persistent inequities in immunization coverage

Maternal and child health

PLoS NTDs • Article: Epidemiology of Congenital Rubella Syndrome (CRS) in India, 2016-18, based on data from sentinel surveillance

The Lancet Global Health • Article: Estimates of aid for reproductive, maternal, newborn, and child health: findings from application of the Muskoka2 method, 2002–17

The Lancet • World Report: Ghana takes on sickle-cell disease

BMJ • Analysis: Equity of resource flows for reproductive, maternal, newborn, and child health: are those most in need being left behind?

BMJ Global Health • Article: Inequalities in early childhood care and development in low/middle-income countries: 2010–2018 and comment: Melissa Gladstone: To move forwards from ensuring children globally not only survive but thrive, we need better ways of measuring child development

Conflict, migration and health

BMJ • Editorial: Humanitarian catastrophe for civilians in northwest Syria

Conflict & Health • Article ***MENTIONS MSF***: Applying trauma systems concepts to humanitarian battlefield care: a qualitative analysis of the Mosul trauma pathway

The Lancet • Editorial: Safeguarding the health and livelihoods of migrants

The Lancet • Comment: Lancet Migration: global collaboration to advance migration health

BMJ Opinion • Blog ***MENTIONS MSF***: Julian Sheather: No more safe haven—Greece announces a wall in the sea


Malaria Journal • Article: Physical integrity and survivorship of long-lasting insecticidal nets distributed to households of the same socio-cultural community in Benin, West Africa

Malaria Journal • Article: A 2-month intervention study of preventive clothing against mosquito bites among malnourished and well-nourished children under 5 years of age living on the Atlantic Ocean Coast of Lagos, Southwest Nigeria

Malaria Journal • Review: Plasmodium falciparum pre-erythrocytic stage vaccine development

Global health

WHO Bulletin •
Article: Universal health coverage provisions for women, children and adolescents

WHO Bulletin • Article: Reforms for financial protection schemes towards universal health coverage, Senegal

WHO Bulletin • Article: Purchasing reforms and tracking health resources, Kenya

The Lancet Global Health • Comment: The elimination of measles in Iran

BMJ Global Health • Article: Are low and middle-income countries prioritising high-value healthcare interventions?


WHO Bulletin •
Article: HIV prevention and care as part of universal health coverage

WHO Bulletin • Article ***MSF AUTHOR***: Tailored HIV programmes and universal health coverage

The Lancet Global Health • Article: Effectiveness and cost-effectiveness of group support psychotherapy delivered by trained lay health workers for depression treatment among people with HIV in Uganda: a cluster-randomised trial

The Lancet HIV • Article: Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa: modelling to inform treatment guidelines


Int J Infectious Diseases • Article ***MSF AUTHOR***: MDR/XDR-TB management of patients and contacts: challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network


The Lancet Planetary Health •
Comment: 2019-nCoV in context: lessons learned?

The Lancet • Comment: Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury

The Lancet • Comment: What to do next to control the 2019-nCoV epidemic?

The Lancet • World Report: What next for the coronavirus response?

The Lancet • Comment: Offline: 2019-nCoV—“A desperate plea”

Sign up to the Medical Press Review email 

Receive the MSF Medical Press Review straight to your inbox!